Trials / NCT00000116
Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A
Completed Phase 3 Supplement / diet
- Sponsor
- Carol Weigel DiFranco
- Treatment
- Vitamin A; Docosahexaenoic acid; Control fatty acid
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 55 Years
- Enrollment
- 221 participants
- Started
- 1996-05
- Main results expected
- 2002-09
- Results posted
- Not yet
- Record last updated
- 2023-03-08
What the study is testing
The purpose of this trial is to determine whether a nutritional supplement in addition to vitamin A will slow the course of retinitis pigmentosa.
Where it runs
United States (1)
- Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts